Inhibition of signal transducer and activator of transcription 5 by the inhibitor of janus kinases stimulates dormant human leukemia CD34<sup>+</sup>/CD38<sup>−</sup> cells and sensitizes them to antileukemia agents

Takayuki Ikezoe(Fukushima Medical University), Akihito Yokoyama(Kōchi University)
International Journal of Cancer
December 2, 2010
10.1002/ijc.25806
Cited by 22

Related Papers

Mitochondrial STAT3 exacerbates LPS-induced sepsis by driving CPT1a-mediated fatty acid oxidation
|Theranostics|2021|156
A novel treatment strategy targeting Aurora kinases in acute myelogenous leukemia
|Molecular Cancer Therapeutics|2007|131
Blockade of mTOR signaling potentiates the ability of histone deacetylase inhibitor to induce growth arrest and differentiation of acute myelogenous leukemia cells
|Leukemia|2008|86
Downregulation of miR‐217 correlates with resistance of ph<sup>+</sup> leukemia cells to <scp>ABL</scp> tyrosine kinase inhibitors
|Cancer Science|2013|60
Expression of p‐JAK2 predicts clinical outcome and is a potential molecular target of acute myelogenous leukemia
|International Journal of Cancer|2011|47